# A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

> **NCT06197178** · PHASE1 · TERMINATED · sponsor: **Peking University** · enrollment: 17 (actual)

## Conditions studied

- Advanced Gastrointestinal Tumors

## Interventions

- **BIOLOGICAL:** LCAR-G08 cells

## Key facts

- **NCT ID:** NCT06197178
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-12-28
- **Primary completion:** 2025-10-22
- **Final completion:** 2025-10-22
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** achieved the proof of concept
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06197178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06197178, "A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06197178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*